Treatment of Recurrent Aneurysmal Bone Cyst in a Dog Using Bone Morphogenetic Protein-2-loaded Alginate Microbeads
Lee C., Kang KW., Kang BJ.
Case Report / Series on Hip, published in In Vivo (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Case Report / Series
- Journal
- In Vivo (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40579036
- PMCID
- PMC12223652
- DOI
- 10.21873/invivo.13997
Abstract (original English)
Background/aim Aneurysmal bone cysts (ABCs) are benign osteolytic lesions associated with lameness and present therapeutic challenges due to their frequent recurrence following surgery. This case report describes the surgical management and long-term outcomes of recurrent femoral ABC in a dog treated with multiple adjuvant therapies, including bone morphogenetic protein-2 (BMP-2)-loaded alginate microbeads. Case report A 2-year-old neutered male Golden Retriever presented with right hindlimb lameness. Three months before, the dog underwent initial surgical curettage and bone grafting of a femoral lesion, confirmed as ABC by histopathology. Radiographs revealed an osteolytic lesion in the right distal femur with resorption of previously applied bone grafts. Revision surgery involved curettage and a high-speed burring, followed by filling the defect with cancellous bone autografts, bone marrow, BMP-2-loaded alginate microbeads, and BMP-2-soaked cancellous bone allograft chips. The dog restored normal gait within two months postoperatively. Follow-up radiographs indicated progressive bone formation without recurrence. The dog remained asymptomatic 29 months after the revision surgery. Conclusion The combined use of a high-speed burr, BMP-2-loaded alginate microbeads, and bone graft materials resulted in favorable clinical outcomes in recurrent ABC, without recurrence up to 29 mont
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level ASystematic ReviewEurope PMC
The Role of Exosome-miRNA as Biomarkers of Alzheimer's Disease: A Systematic Review of Case-Control and Longitudinal Studies
Systematic Review with a reported sample of 3046 on Neuroinflammation, published in Actas Esp Psiquiatr (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3046
Actas Esp Psiquiatr - Level AMeta-analysisEurope PMC
Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Neuroinflammation, published in Front Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurosci - Level AMeta-analysisEurope PMC
Efficacy of stem cell therapy for achilles tendon rupture: a systematic review and meta-analysis based on animal studies
Meta-analysis on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol